WEB™ Intrasaccular Embolization
French Observatory: WEB™ French Observatory of the WEB Aneurysm Embolization System
"This comparative study shows increased use of WEB treatment in ruptured, small, and anterior communicating artery aneurysms when using WEB SL/SLS. There was a trend toward fewer thromboembolic complications with the WEB SL/SLS. With both the WEB DL and WEB SL/SLS, the treatment was safe, with low morbidity and no mortality."
- Patients
61
- Country
France
- Clinical Centers
10
- Design
Single arm prospective
- Scope
Patients 18-75 y.o., with bifurcation intracranial aneurysm, ruptured or unruptured, H&H<4, treatable with WEB DL or WEB.
- Purpose
Assessment of safety and efficacy at 1 year in an observatory registry.
Endpoints
Efficacy : Durability of aneurysm occlusion at 12 months compared to post-procedure imaging (assessed by Corelab)
Efficacy results
At 12 months:
Complete occlusion: 51.7% / Adequate occlusion: 79.3%
Safety results
At 30 days:
Morbidity: 3.2%
Mortality: 0%
At 12 months:
Morbidity: 0%
Mortality: 3.4%
Study publications
LINK TO STUDY PAGE ClinicalTrials.gov ID NCT01975233
Please refer to IFU for the full list of risks, contraindications, warnings, and precautions.
Explore more studies
Request more information
By submitting, you agree to our privacy policy.